Кина - Кинески - CFDA (药监局 - 中国食品和药物管理局)

sanofi pasteur s.a. - 注射剂 - 0.5ml/支（预填充注射器）

Кина - Кинески - CFDA (药监局 - 中国食品和药物管理局)

sanofi pasteur s.a. - 注射剂 - 0.5ml/支（预填充注射器）

Кина - Кинески - CFDA (药监局 - 中国食品和药物管理局)

sanofi pasteur s.a. - 注射剂 - 本品为两个包材包装,其一为百白破脊髓灰质炎疫苗,混悬液,每支0.5ml;其二为b型流感嗜血杆菌结合疫苗,冻干粉。使用前两者混?

Кина - Кинески - CFDA (药监局 - 中国食品和药物管理局)

sanofi pasteur s.a. - 注射剂 - 本品为两个包材包装,其一为百白破脊髓灰质炎疫苗,混悬液,每支0.5ml;其二为b型流感嗜血杆菌结合疫苗,冻干粉。使用前两者混合。其中百白破脊髓灰质炎疫苗含:无细胞百日咳疫苗效价不低于4.0iu;白喉疫苗效价不低于30iu;破伤风疫苗效价不低于40iu;1型

Тајван - Кинески - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

賽諾菲股份有限公司 台北市信義區松仁路3號7樓 (97168356) - b/colorado/06/2017-like virus (b/maryland/15/2016, reassortant nymc bx-69a);;a/michigan/45/2015 (h1n1) pdm09 - like strain (a/michigan/45/2015, nymc x-275);;a/singapore/infimh-16-0019/2016 (h3n2)-like virus (a/singapore/infimh-16-0019/2016 , reassortant ivr-186) - 滅菌懸液注射劑 - 主成分 (each 0.5ml immunizing dose conains:) ; a/singapore/infimh-16-0019/2016 (h3n2)-like virus (a/singapore/infimh-16-0019/2016 , reassortant ivr-186) (8012002468) ug haemagglutinin; a/michigan/45/2015 (h1n1) pdm09 - like strain (a/michigan/45/2015, nymc x-275) (8012002490) ug haemagglutinin; b/colorado/06/2017-like virus (b/maryland/15/2016, reassortant nymc bx-69a) (8012006800) ug haemagglutinin - influenza, inactivated, split virus or surface antigen - 預防流感。

Кина - Кинески - CFDA (药监局 - 中国食品和药物管理局)

sanofi pasteur s.a. - 注射剂 - 5ml/瓶。本品每1次人用剂量为0.5ml，含有脊髓灰质炎病毒1型40du、脊髓灰质炎病毒2型8du、脊髓灰质炎病毒3型32du

Кина - Кинески - CFDA (药监局 - 中国食品和药物管理局)

sanofi pasteur s.a. - 注射剂 - 0.5ml/支（预填充注射器）

Кина - Кинески - CFDA (药监局 - 中国食品和药物管理局)

sanofi pasteur s.a. - 注射剂 - 0.5ml/支（预填充注射器）

Тајван - Кинески - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

賽諾菲股份有限公司 台北市信義區松仁路3號7樓 (97168356) - purified filamentous haemagglutinin;;inactivated poliovirus vaccine type i;;pertussis bordetella;;inactivated poliovirus vaccine type ii;;diphtheria toxoid purified;;inactivated poliovirus vaccine type iii;;tetanus toxoid purified;;purified pertussis toxoid - 懸浮注射液 - 主成分 () ; purified pertussis toxoid (8004001630) ug; diphtheria toxoid purified (8008000110) purified diphtheria toxoid≧30iuiu; tetanus toxoid purified (8008000210) purified tetanus toxoid≧40iuiu; pertussis bordetella (8012000110) bordetella pertussis antigens; inactivated poliovirus vaccine type i (8012002201) type 1 poliovirus (inactivated)du; inactivated poliovirus vaccine type ii (8012002202) type 2 poliovirus (inactivated)du; inactivated poliovirus vaccine type iii (8012002203) type 3 poliovirus (inactivated)du; purified filamentous haemagglutinin (9200050310) ug - diphtheria-pertussis-poliomyelitis-tetanus - 適用於出生2個月至未滿13歲孩童的主動免疫接種，以預防白喉、破傷風、百日咳及小兒麻痺。

Тајван - Кинески - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

賽諾菲股份有限公司 台北市信義區松仁路3號7樓 (97168356) - pertussis toxoid;;filamentous haemagglutinin;;inactivated poliovirus vaccine type i;;inactivated poliovirus vaccine type iii;;diphtheria toxoid;;polysaccharide of haemophilus influenzae type b;;tetanus toxoid;;conjugated to the tetanus protein;;pertussis bordetella;;inactivated poliovirus vaccine type ii - 凍晶注射劑及懸浮注射液 - pertussis toxoid (8004001620) ug; diphtheria toxoid (8008000100) diphtheria toxoid….……≧30 iuiu; tetanus toxoid (8008000200) tetanus toxoid..……………≧40 iuiu; conjugated to the tetanus protein (8008000230) 18-30ugug; pertussis bordetella (8012000110) bordetella pertussis antigens; inactivated poliovirus vaccine type i (8012002201) type 1 poliovirus (inactivated)du; inactivated poliovirus vaccine type ii (8012002202) type 2 poliovirus (inactivated)du; inactivated poliovirus vaccine type iii (8012002203) type 3 poliovirus (inactivated)du; polysaccharide of haemophilus influenzae type b (8012020000) ug; filamentous haemagglutinin (9200050300) ug - diphtheria-haemophilus influenzae b-pertussis-poliomyelitis-tetanus - 適用於出生2個月至7歲孩童的主動免疫接種，以預防白喉、破傷風、百日咳、小兒麻痺及侵襲性b型嗜血桿菌疾病。